Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells

Biochemical and Biophysical Research Communications

Volumn 441, Issue 3, 2013, Pages 586-592

  Rentala, Satyanarayana ^a   Chintala, Ramakrishna ^a   Guda, Manohar ^b   Chintala, Madhuri ^b   Komarraju, Aruna Lakshmi ^a   Mangamoori, Lakshmi Narasu ^c  

^a GITAM UNIVERSITY   (India)

^b King George Hospital   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Differentiation and signaling cascade; FAK; Integrin; Prostate cancer stem cell; ROCK1

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; ANTIBODY; ATORVASTATIN; BETA1 INTEGRIN; BIOLOGICAL MARKER; CD133 ANTIGEN; FOCAL ADHESION KINASE; RHO KINASE;

ARTICLE; BLOOD; CELL ADHESION; CELL DIFFERENTIATION; ENDOTHELIUM; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; STEM CELL; WESTERN BLOTTING;

DIFFERENTIATION AND SIGNALING CASCADE; FAK; INTEGRIN; PROSTATE CANCER STEM CELL; ROCK1;

AGED; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL DIFFERENTIATION; FOCAL ADHESION KINASE 1; GLYCOPROTEINS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; PYRROLES; RHO-ASSOCIATED KINASES; TUMOR CELLS, CULTURED;

EID: 84888298957     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.112     Document Type: Article

References (20)

1. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
2. Itoh K., Yoshioka K., Akedo H., et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 1990, 5:221-225.
3. Hynes R.O. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992, 69:11-25.
4. Moschos S.J., Drogowski L.M., Reppert S.L., et al. Integrins and cancer. Oncology 2007, 21:13-20.
5. Toepfer N., Childress C., Parikh A., et al. Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription. Cancer Biol. Ther. 2011, 12:691-699.
6. Parikh A., Childress C., Deitrick K., et al. Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. Prostate 2010, 70:971-981.
7. Collins A.T., Berry P.A., Hyde C., et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
8. Maitland N.J., Collins A.T. Prostate cancer stem cells: a new target for therapy. J. Clin. Oncol. 2008, 26:2862-2870.
9. Al-Hajj M., Wicha M.S., Benito-Hernandez A., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 2003, 100:3983-3988.
10. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer and cancer stem cells. Nature 2001, 414:105-111.
11. Patrawala L., Calhoun T., Schneider-Broussard R., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
12. Pellacani D., Oldridge E.E., Collins A.T., et al. Prominin-1 (CD133) expression in the prostate and prostate cancer: a marker for quiescent stem cells. Adv. Exp. Med. Biol. 2013, 777:167-184.
13. Rentala Satyanarayana, Yalavarthy Prameela Devi, Mangamoori Lakshmi Narasu α1 and β1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells. Asian J. Androl. 2010, 12:548-555.
14. Fornaro M., Manes T., Languino L.R. Integrins and prostate cancer metastases. Cancer Metastasis Rev. 2001, 20:321-331.
15. Vainio Paula, Lehtinen Laura, Mirtti Tuomas, et al. Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. Oncotarget 2011, 2:1176-1190.
16. Sekine Y., Furuya Y., Nishii M., et al. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Biochem. Biophys. Res. Commun. 2008, 372:356-361.
17. Gupta P.B., Onder T.T., Jiang G., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
18. Relja Borna, Meder Frank, Wang Minhong Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int. J. Oncol. 2011, 38:879-885.
19. Guan J.L. Role of focal adhesion kinase in integrin signaling. Int. J. Biochem. Cell Biol. 1997, 29:1085-1096.
20. Witz I.P., Witz I.P. Yin-yang, activities and vicious cycles in the tumor microenvironment. Cancer Res. 2008, 68:9-13.